Acucela
Seattle
About Acucela
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Total funding: $439.6K
- Funding stage: IPO
- Last round: Series Unknown (Sep 2009)
- Ticker: tyo:4589
- Website: acucela.com
- Phone: +1-425-527-3260
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/acucela-1167560 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.